Quote:The study is searchable and OHM knows about it.
It dont prime.
"Yes, studies indicate that maraviroc can lower PD-L1 (Programmed Death-Ligand 1) expression and inhibit PD-L1-mediated immune evasion in certain cancer models.
That was the study where I first saw that maraviroc lowered PD-L1. The question at the time was by how much. In either 2021 or 2022 a study was released showing around a 75% drop in PD-L1. This later 2024 study shows around a 50% drop.
https://www.cell.com/iscience/fulltext/S2589-0042(24)00896-4